4-hydroxy-25-desoxyneorollinicin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, A; Bharathkumar, H; Bulusu, KC; Dai, X; Deivasigamani, A; Fuchs, JE; Hui, KM; Kumar, AP; Li, F; Lobie, PE; Mohan, CD; Pandey, V; Rangappa, KS; Rangappa, S; Sethi, G; Shanmugam, MK | 1 |
| Block, T; Choudhari, SR; Harris, G; Jacob, GS; Khan, MA; Picker, D; Shailubhai, K | 1 |
2 other study(ies) available for 4-hydroxy-25-desoxyneorollinicin and Liver Neoplasms
| Article | Year |
|---|---|
Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Janus Kinase 2; Liver Neoplasms; Mice; Mice, Nude; Phosphorylation; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Spiro Compounds; STAT3 Transcription Factor; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cyclooxygenase 2; Enzyme Activation; Gene Expression Regulation, Viral; Hepacivirus; Hepatitis B virus; Humans; Interleukin-6; Liver Neoplasms; Models, Biological; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Spiro Compounds; STAT3 Transcription Factor; Virus Replication | 2007 |